These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 35384495)

  • 1. Association between preoperative biologic use and surgical morbidity in patients with Crohn's disease.
    Uchino M; Ikeuchi H; Horio Y; Kuwahara R; Minagawa T; Kusunoki K; Goto Y; Beppu N; Ichiki K; Ueda T; Nakajima K; Ikeda M
    Int J Colorectal Dis; 2022 May; 37(5):999-1010. PubMed ID: 35384495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and predictors of surgical site infections after bowel resection for Crohn's disease: the role of dual-ring wound protector.
    Ge X; Tang S; Qi W; Liu W; Lv J; Cao Q; Zhou W; Cai X
    Int J Colorectal Dis; 2019 May; 34(5):879-887. PubMed ID: 30868209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoalbuminaemia, Not Biologic Exposure, Is Associated with Postoperative Complications in Crohn's Disease Patients Undergoing Ileocolic Resection.
    Shah RS; Bachour S; Jia X; Holubar SD; Hull TL; Achkar JP; Philpott J; Qazi T; Rieder F; Cohen BL; Regueiro MD; Lightner AL; Click BH
    J Crohns Colitis; 2021 Jul; 15(7):1142-1151. PubMed ID: 33388775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A preoperative low nutritional prognostic index correlates with the incidence of incisional surgical site infections after bowel resection in patients with Crohn's disease.
    Maeda K; Nagahara H; Shibutani M; Otani H; Sakurai K; Toyokawa T; Tanaka H; Kubo N; Muguruma K; Kamata N; Yamagami H; Hirakawa K
    Surg Today; 2015 Nov; 45(11):1366-72. PubMed ID: 25319215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-TNF biologic therapy does not increase postoperative morbidity in pediatric Crohn's patients.
    Lightner AL; McKenna NP; Alsughayer A; Loftus EV; Raffals LE; Faubion WA; Moir C
    J Pediatr Surg; 2019 Oct; 54(10):2162-2165. PubMed ID: 30773391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are Biologics Safe in the Immediate Postoperative Period? A Single-Center Evaluation of Consecutive Crohn's Surgical Patients.
    Lightner AL; Grass F; Alsughayer AM; Harmsen WS; Petersen M; Loftus EV
    Dis Colon Rectum; 2020 Jul; 63(7):934-943. PubMed ID: 32149787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Autologous Flap Reconstruction in Patients with Crohn's Disease Undergoing Abdominoperineal Resection.
    Ganesh Kumar N; Khouri AN; Byrn JC; Kung TA
    Dis Colon Rectum; 2021 Apr; 64(4):429-437. PubMed ID: 33395136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative chemotherapy and corticosteroids: independent predictors of cranial surgical-site infections.
    Lieber BA; Appelboom G; Taylor BE; Lowy FD; Bruce EM; Sonabend AM; Kellner C; Connolly ES; Bruce JN
    J Neurosurg; 2016 Jul; 125(1):187-95. PubMed ID: 26544775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative Safety Profile of Minimally Invasive Ileocolonic Resections for Crohn's Disease in the Era of Biologic Therapy.
    Abd El Aziz MA; Abdalla S; Calini G; Saeed H; Stocchi L; Merchea A; Colibaseanu DT; Shawki S; Larson DW
    J Crohns Colitis; 2022 Aug; 16(7):1079-1088. PubMed ID: 35045164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for incisional and organ space surgical site infections after liver resection are different.
    Kokudo T; Uldry E; Demartines N; Halkic N
    World J Surg; 2015 May; 39(5):1185-92. PubMed ID: 25561190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between preoperative tumor necrosis factor alpha inhibitor and surgical site infection after surgery for inflammatory bowel disease: a systematic review and meta-analysis.
    Uchino M; Ikeuchi H; Shimizu J; Ohge H; Haji S; Mizuguchi T; Mohri Y; Yamashita C; Kitagawa Y; Suzuki K; Kobayashi M; Kobayashi M; Sakamoto F; Yoshida M; Mayumi T; Hirata K; Takesue Y
    Surg Today; 2021 Jan; 51(1):32-43. PubMed ID: 32277281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for surgical site infection and association with infliximab administration during surgery for Crohn's disease.
    Uchino M; Ikeuchi H; Matsuoka H; Bando T; Ichiki K; Nakajima K; Tomita N; Takesue Y
    Dis Colon Rectum; 2013 Oct; 56(10):1156-65. PubMed ID: 24022533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between multiple immunosuppressive treatments before surgery and surgical morbidity in patients with ulcerative colitis during the era of biologics.
    Uchino M; Ikeuchi H; Bando T; Chohno T; Sasaki H; Horio Y; Kuwahara R; Minagawa T; Goto Y; Ichiki K; Nakajima K; Takahashi Y; Ueda T; Takesue Y
    Int J Colorectal Dis; 2019 Apr; 34(4):699-710. PubMed ID: 30685791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective Cohort Study to Investigate the Safety of Preoperative Tumor Necrosis Factor Inhibitor Exposure in Patients With Inflammatory Bowel Disease Undergoing Intra-abdominal Surgery.
    Cohen BL; Fleshner P; Kane SV; Herfarth HH; Palekar N; Farraye FA; Leighton JA; Katz JA; Cohen RD; Gerich ME; Cross RK; Higgins PDR; Tinsley A; Glover S; Siegel CA; Bohl JL; Iskandar H; Ji J; Hu L; Sands BE
    Gastroenterology; 2022 Jul; 163(1):204-221. PubMed ID: 35413359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of active drainage for preventing postoperative organ/space surgical site infections in patients with Crohn's disease.
    Ikeshima R; Mizushima T; Takahashi H; Haraguchi N; Nishimura J; Hata T; Matsuda C; Ikenaga M; Nakajima K; Yamamoto H; Murata K; Doki Y; Mori M
    Surg Today; 2018 Jan; 48(1):25-32. PubMed ID: 28608250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologics and 30-Day Postoperative Complications After Abdominal Operations for Crohn's Disease: Are There Differences in the Safety Profiles?
    Lightner AL; McKenna NP; Alsughayer A; Harmsen WS; Taparra K; Parker ME; Raffals LE; Loftus EV
    Dis Colon Rectum; 2019 Nov; 62(11):1352-1362. PubMed ID: 31567927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors Associated with Short-Term Morbidity in Patients Undergoing Colon Resection for Crohn's Disease.
    Aydinli HH; Aytac E; Remzi FH; Bernstein M; Grucela AL
    J Gastrointest Surg; 2018 Aug; 22(8):1434-1441. PubMed ID: 29663305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative outcomes in vedolizumab-treated Crohn's disease patients undergoing major abdominal operations.
    Lightner AL; McKenna NP; Tse CS; Raffals LE; Loftus EV; Mathis KL
    Aliment Pharmacol Ther; 2018 Mar; 47(5):573-580. PubMed ID: 29250800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crohn's disease but not diverticulitis is an independent risk factor for surgical site infections in colectomy.
    Wideroff M; Xing Y; Liao J; Byrn JC
    J Gastrointest Surg; 2014 Oct; 18(10):1817-23. PubMed ID: 25091841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative Outcomes in Ustekinumab-Treated Patients Undergoing Abdominal Operations for Crohn's Disease.
    Lightner AL; McKenna NP; Tse CS; Hyman N; Smith R; Ovsepyan G; Fleshner P; Crowell K; Koltun W; Ferrante M; D'Hoore A; Lauwers N; Verstockt B; Spinelli A; DiCandido F; Raffals LE; Mathis KL; Loftus EV
    J Crohns Colitis; 2018 Mar; 12(4):402-407. PubMed ID: 29220430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.